Gadofosveset trisodium Alternatives Compared
| Gadofosveset trisodium | Multihance (gadobenate dimeglumine) | Gadobenate dimeglumine |
|
|---|
| Gadofosveset trisodium | Multihance (gadobenate dimeglumine) | Gadobenate dimeglumine |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Magnetic Resonance Angiography. Gadofosveset trisodium may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for CNS Magnetic Resonance Imaging, Magnetic Resonance Angiography. Multihance may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for CNS Magnetic Resonance Imaging, Magnetic Resonance Angiography. Gadobenate dimeglumine may also be used for purposes not listed in this medication guide. |
||||||||
| More about Gadofosveset trisodium | More about Multihance (gadobenate dimeglumine) | More about Gadobenate dimeglumine | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Gadofosveset trisodium side effects |
View all Multihance side effects |
View all Gadobenate dimeglumine side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Multihance prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
N/A |
||||||||
| Brand Names | ||||||||||
|
N/A |
N/A |
Multihance | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
18.9 hours |
2.62 hours |
2.62 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 30 drugs are known to interact with Gadofosveset trisodium:
|
A total of 55 drugs are known to interact with Multihance:
|
A total of 55 drugs are known to interact with Gadobenate dimeglumine:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
| First Approval Date | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
|
N/A |
N/A |
|||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.